Jean-Pol Detiffe

Jean-Pol Detiffe is the current Chief Strategy & Innovation Officer at OncoDNA, a cancer theranostic company. Jean-Pol has also previously served as a member of the board at BioWin and as the Founder & CEO of DNAVision SA. Most recently, Detiffe was responsible for Biotechnology Business Development at Quality Assistance.

Detiffe has over 20 years of experience in the biotechnology industry. Jean-Pol founded DNAVision in 2004 and served as its CEO until 2012. Under their leadership, the company became a service provider in DNA/RNA analyses. In 2009, they joined the board of BioWin, where they served as a member until 2012. Detiffe has also worked as a business development consultant, helping companies to develop new market opportunities.

Detiffe’s experience and knowledge in the biotechnology field has made him an expert in the development and commercialization of new products and services. Jean-Pol is currently using their skills to help OncoDNA innovate and grow its business.

Jean-Pol Detiffe is an industrial pharmacist who received their Bachelor in Business Administration (IAG) from the Université catholique de Louvain. Jean-Pol also holds an agregation in sciences from the same school. Jean-Pol is currently a pharmacist at the Université catholique de Louvain.

Jean-Pol Detiffe reports to Bernard Courtieu, CEO. Jean-Pol Detiffe works with Pierre Flamant - CFO, Emmanuel Martin - COO, and Bérengère Genin - Head of Academics, Research Business Unit.